Calamos Advisors »

Summit Therapeutics shares owned by Calamos Advisors

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $385k 19k 20.66
2025-06-30 $492k 23k 21.28
2025-03-31 $463k 24k 19.29
2024-12-31 $425k 24k 17.85
2024-09-30 $1.0M 47k 21.90